Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/19/2012EP2533807A2 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies
12/19/2012EP2533803A1 Lactocepins for use in the treatment of ip-10-mediated inflammatory diseases
12/19/2012EP2533802A2 Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
12/19/2012EP2533801A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention
12/19/2012EP2533800A2 Liquid formulation of follicle stimulating hormone
12/19/2012EP2533799A2 Methods for the use of progestogen as a glucocorticoid sensitizer
12/19/2012EP2533798A2 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
12/19/2012EP2533797A1 Complement factor h for oxidative stress disease conditions
12/19/2012EP2533796A1 Methods of treating glucose metabolism disorders
12/19/2012EP2533795A2 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES
12/19/2012EP2533794A1 Protein domains and uses therefor
12/19/2012EP2533793A2 Compositions and uses of lectins
12/19/2012EP2533792A2 Chemical preparation of polyubiquitin chains
12/19/2012EP2533791A1 Leucine/peptide composition and method of formulation
12/19/2012EP2533789A1 Methods for improving sperm functionality
12/19/2012EP2533771A2 Transdermal therapeutic system for the administration of peptides
12/19/2012EP2533758A1 Orally administrable pharmaceutical pellet of epidermal growth factor
12/19/2012EP2533634A1 Neuroprotection in demyelinating diseases
12/19/2012CN102834512A Metal salen complex derivative and process for production thereof
12/19/2012CN102834408A Aromatic-cationic peptides and uses of same
12/19/2012CN102834111A Process for production and purification of recombinant lysosomal alpha-mannosidase
12/19/2012CN102834110A Methods and compositions using peroxiredoxin 1 (PRX1) as an adjuvant
12/19/2012CN102834109A Stable growth hormone compounds
12/19/2012CN102834108A Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
12/19/2012CN102834107A Treatment of nerve injuries
12/19/2012CN102834106A Methods for producing an immune response to tuberculosis
12/19/2012CN102834105A Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy
12/19/2012CN102834104A Methods and compositions to treat hemorrhagic conditions of the brain
12/19/2012CN102834091A A fast dissolving pharmaceutical composition
12/19/2012CN102827814A Preparation method of anti-oxidant
12/19/2012CN102827291A Recombinant fusion protein PTD-HSP27 and use thereof
12/19/2012CN102827288A Acid-activated CSP targeted antimicrobial peptide and preparation method and applications thereof
12/19/2012CN102827286A Fusion protein of Exendin-4 and mutational human serum albumin, and preparation method of fusion protein
12/19/2012CN102827285A Mouse-specific anti-fertility polypeptide
12/19/2012CN102827284A Exendin or analogue containing polyethylene glycol group and preparation and application thereof
12/19/2012CN102827283A Transgenic non-human animals capable of producing heterologous antibodies
12/19/2012CN102827277A Anti-human serum albumin single-chain antibody and method for connecting polypeptide drugs to carbon end thereof
12/19/2012CN102827270A Pegylated exenatide ramification and use thereof
12/19/2012CN102827269A Thymulin alpha 1 analog and preparation method thereof
12/19/2012CN102827267A Humanized pika leptin protein, gene coding same and application thereof
12/19/2012CN102827266A Application of ligand antrum mucosal protein-18(AMP-18) of laminin receptor in treatment of tumor
12/19/2012CN102827265A Novel gene of sorting nexin (SNX) family and use thereof
12/19/2012CN102827257A Peptide fragment of gp96 protein and applications thereof
12/19/2012CN102827256A Preparation and application of ginseng glycoprotein
12/19/2012CN102827255A Antibacterial peptide GW13 and its preparation method and use
12/19/2012CN102827253A Micro-molecular polypeptide inhibiting inflammatory response, and application thereof
12/19/2012CN102827250A Fatty acid-modificatory amphiphilic cation self-assembling peptide and application thereof
12/19/2012CN102827248A Tripeptide with Japanese encephalitis virus infection resistance and application thereof
12/19/2012CN102827247A New sansanmycins, and their uses as anti-tuberculous medicines
12/19/2012CN102827246A Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof
12/19/2012CN102827245A N-[2-(3-acetyl-2-oxo-2H-pyridine-1-yl)-acetyl]-L-amino acid, synthetic method and application thereof
12/19/2012CN102824646A Conjugate of polyethylene glycol interferon
12/19/2012CN102824630A Pharmaceutical composition for treating chicken proventriculitis and preparation method of pharmaceutical composition
12/19/2012CN102824629A Immune hematogenesis anti-cancer preparation for treating leukemia and preparation method thereof
12/19/2012CN102824628A Application of chemokine-like factor derived polypeptides in inhibition of inflammatory lesions
12/19/2012CN102824627A Snake bone calcium capsule powder and preparation method thereof
12/19/2012CN102824332A Preparation method of antimicrobial peptide slow-release microcapsules
12/19/2012CN102824328A Collagen effervescent tablet
12/19/2012CN102824306A Folic acid modified chitosan coated plasmid nanoparticles and preparation method thereof
12/19/2012CN102823859A Composition comprising medlar, chrysanthemum or honeysuckle and calcium gluconate
12/19/2012CN102823723A Nucleoside polypeptide composition as well as preparation method thereof and purpose thereof
12/19/2012CN102429858B Preparation method and application of sustained-release BIO/IGF (6-bromoindirubin-3'-oxime/insulin-like growth factor) composite hydrogel
12/19/2012CN102389402B Recombinant bovine basic fibroblast growth factor freeze-dried formulation for external application
12/19/2012CN102357243B Recombinant cattle basic fibroblastic growth factor eye drops
12/19/2012CN102357242B Recombination cattle alkaline fibroblast growth factor gel
12/19/2012CN102212110B Beta-lactamase inhibitory peptide and application thereof
12/19/2012CN102174518B Main cis-acting element of shrimp white spot syndrome virus (WSSV) iel promoter and transcription factor combined with same and application
12/19/2012CN102146364B Serine protease isolated from the venom of bombus ignitus as fibrinogenolytic and fibrinolytic enzymes
12/19/2012CN101759806B Cytoplasm leader peptide (CTD)-containing human epidermal growth factor fusion protein (CTD-hEGF) prepared by using hydroxylamine cutting method and application thereof
12/19/2012CN101678063B Methods of use of epsilon inhibitor compounds for the attenuation of pain
12/19/2012CN101584853B 一种地龙蛋白多肽制剂 An earth dragon polypeptide formulations
12/19/2012CN101541336B Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent
12/19/2012CN101437540B Melanocortin receptor binding mimetibodies, compositions, methods and uses
12/19/2012CN101365474B Interferon lambda therapy for treatment of respiratory diseases
12/19/2012CN101337992B Fusion protein of urokinase type plasminogen activator a chain and melittin and preparation thereof
12/19/2012CN101301475B Peg化因子vii糖型 Peg factor vii sugar type
12/19/2012CN101163497B Erythrocytes containing arginine deiminase
12/19/2012CN101065398B Peptides and APL-type derivatives of hsp60 and pharmaceutical compositions
12/18/2012US8334368 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
12/18/2012US8334275 Cellular genes regulated by HIV-1 infection and methods of use thereof
12/18/2012US8334266 Process for and intermediates in the preparation of canfosfamide and its salts
12/18/2012US8334265 Method of treatment of photodermatoses
12/18/2012US8334263 Analgesic methods and compositions
12/18/2012US8334262 Cognitive function
12/18/2012US8334261 Osteopenia animal model
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012US8334258 Administering gonadotropin-hormone-releasing hormone (GnRH) antagonist peptide for inducing/enhancing apoptosis of breast cancer or malignant melanoma or gynaecological cancer
12/18/2012US8334257 Methods and compositions for delivering active agents with enhanced pharmacological properties
12/18/2012US8334256 Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor
12/18/2012US8334255 Peptide and treatment for HIV-1 infection
12/18/2012US8334254 Recombinant lactoferrins, methods of production from plants and uses thereof
12/18/2012US8334253 Cosmetic and dermatological formulations of MNTF peptides
12/18/2012US8334125 Nucleic acids encoding nitrilases
12/18/2012US8334102 Human CD28 specific monoclonal antibodies for antigen-nonspecific activation of T-lymphocytes
12/18/2012US8334000 Anti-angiogenic extracts from pomegranate
12/18/2012US8333976 Processes for inhibiting development of allergic disease
12/18/2012US8333974 Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
12/18/2012US8333965 Anti-inteferon alpha monoclonal antibodies and methods for use
12/18/2012US8333963 Method of inhibiting osteoclast activity
12/18/2012US8333962 Controlled release multidrug formulations for spinal cord injury
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 3163